BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 26984187)

  • 1. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P; Sinniger J; El Oussini H; Scekic-Zahirovic J; Dieterlé S; Dengler R; Meyer T; Zierz S; Kassubek J; Fischer W; Dreyhaupt J; Grehl T; Hermann A; Grosskreutz J; Witting A; Van Den Bosch L; Spreux-Varoquaux O; ; Ludolph AC; Dupuis L
    Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
    Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
    Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis.
    Bolborea M; Vercruysse P; Daria T; Reiners JC; Alami NO; Guillot SJ; Dieterlé S; Sinniger J; Scekic-Zahirovic J; Londo A; Arcay H; Goy MA; de Tapia CN; Thal DR; Shibuya K; Otani R; Arai K; Kuwabara S; Ludolph AC; Roselli F; Yilmazer-Hanke D; Dupuis L
    Acta Neuropathol; 2023 Jun; 145(6):773-791. PubMed ID: 37058170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis.
    Cimini S; Rizzardini M; Biella G; Cantoni L
    J Neurochem; 2014 May; 129(3):413-25. PubMed ID: 24359187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
    Schütz B; Reimann J; Dumitrescu-Ozimek L; Kappes-Horn K; Landreth GE; Schürmann B; Zimmer A; Heneka MT
    J Neurosci; 2005 Aug; 25(34):7805-12. PubMed ID: 16120782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.
    Audet JN; Soucy G; Julien JP
    Neuroscience; 2012 May; 209():136-43. PubMed ID: 22230045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model of familial amyotrophic lateral sclerosis expressing a mutant superoxide dismutase 1 shows evidence of disordered transport in the vasopressin hypothalamo-neurohypophysial axis.
    González de Aguilar JL; Gordon JW; René F; Lutz-Bucher B; Kienlen-Campard P; Loeffler JP
    Eur J Neurosci; 1999 Dec; 11(12):4179-87. PubMed ID: 10594643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z; Sui Y; Gao W; Cai B; Fan D
    J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
    Staats KA; Van Helleputte L; Jones AR; Bento-Abreu A; Van Hoecke A; Shatunov A; Simpson CL; Lemmens R; Jaspers T; Fukami K; Nakamura Y; Brown RH; Van Damme P; Liston A; Robberecht W; Al-Chalabi A; Van Den Bosch L
    Neurobiol Dis; 2013 Dec; 60():11-7. PubMed ID: 23969236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase.
    Higashi S; Tsuchiya Y; Araki T; Wada K; Kabuta T
    Neurochem Int; 2010 Dec; 57(8):906-13. PubMed ID: 20933032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis.
    Dupuis L; di Scala F; Rene F; de Tapia M; Oudart H; Pradat PF; Meininger V; Loeffler JP
    FASEB J; 2003 Nov; 17(14):2091-3. PubMed ID: 14500553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.